VVOS News and Press, Vivos Therapeutics Inc. From 11/03/23

--News Direct-- Vivos Therapeutics CEO Kirk Huntsman joined Steve Darling from Proactive to share news the company has signed a nationwide distribution agreement in the United States with Lincare, a prominent supplier of in-home respiratory therapy products and services catering to approx...

Vivos Therapeutics (NASDAQ: VVOS) , a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild-to-moderate obstructive sleep apnea (“OSA”) and snoring in adults, has closed its previously announced priva...

LITTLETON, Colo., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS) , a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild-to-mo...

2023-10-31 09:20:32 ET More on Vivos Therapeutics Vivos Therapeutics announces 1-for-25 reverse stock split Vivos Therapeutics, Lincare ink distribution deal Seeking Alpha’s Quant Rating on Vivos Therapeutics Historical earnings data for Vivos Therapeu...

LITTLETON, Colo., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild-to-moderat...

2023-10-27 13:45:10 ET Gainers: Forbion European Acquisition Corp ( FRBN ) +103% . Spectaire Holdings ( SPEC ) +40% . Nerdwallet ( NRDS ) +38% . Integrated Media Technology Limited ( IMTE ) +34% . Envoy Medical ( COCH ) +25% . ...

2023-10-27 10:02:45 ET More on Health Care Select Sector SPDR Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stocks to watch in the Health Care sector as earnings close in BofA reports 10th consecutive week of equity inflows For further detail...

2023-10-26 10:22:03 ET More on Vivos Therapeutics Vivos Therapeutics, Lincare ink distribution deal Vivos Therapeutics GAAP EPS of -$0.18 misses by $0.04, revenue of $3.4M misses by $0.72M Seeking Alpha’s Quant Rating on Vivos Therapeutics Historical e...

LITTLETON, Colo., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for patients suffering from mild-to-moderate obstructive sleep apnea (ȁ...

2023-10-24 09:17:29 ET Medical technology firm Vivos Therapeutics ( NASDAQ: VVOS ) has entered into a U.S. nationwide distribution deal with in-home respiratory therapy products supplier, Lincare. Under the deal, Lincare will have a six-month exclusivity to distribute cert...